Imaging Methods in Infective Endocarditis: To keep in mind
DOI:
https://doi.org/10.37615/retic.v6n2a1Downloads
Metrics
References
Restrepo-Molina G, López JL. Imagen cardíaca en el diagnóstico y manejo de la endocarditis infecciosa. En Ecocardiografía e Imagen Cardiovascular en la Práctica Clínica. Restrepo-Molina G, Lowenstein J, Hernández R., Viera M., Spina S (Editores). Segunda Edición. Editorial Distribuna. 2022.
Restrepo-Molina G, López JL. Endocarditis infecciosa. Fisiopatología, tipos de endocarditis, hallazgos clínicos, métodos de evaluación y criterios diagnósticos.
Em Texto de Cardiología. Sociedad Interamericana de Cardiología. Restrepo-Molina G, Quintana FW, Sosa-Liprandi A, Barbosa M., Baranchuk A (Editores). Segunda Edición. Editorial Distribuna 2020.
Restrepo-Molina G, López JL. Imagen cardiaca en el diagnóstico y manejo de la endocarditis infecciosa. RETIC- Revista de Ecocardiografía Practica y Otras Técnicas de Imagen Cardíaca 2016;2:1-8. doi: https://doi.org/10.37615/retic.n2a2
Baddour LM, Wilson WR, Bayer AS., et al. Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management and complications. A scientific statement for healthcare professionals from the American Heart Association. Circulation 2015; 132:1435-1486. doi: https://doi.org/10.1161/CIR.0000000000000296
Habib GH, Lancellotti P, Antunes MJ, et al. 2015 ESC Guidelines for the management of infective endocarditis. European Heart J 2015; 36:3075-3123. doi: https://doi.org/10.1093/eurheartj/ehv319
Murphy DJ, Din M, Hage FG, Reyes E. Guidelines in review: Comparison of ESC and AHA guidance for the diagnosis and management of infective endocarditis in adults. Journal of Nuclear Cardiology 2019; 26:303-308. doi: https://doi.org/10.1007/s12350-018-1333-5
Cahill TJ, Prendergast BD. Infective endocarditis. Lancet 2016; 387:882-893. doi: https://doi.org/10.1016/S0140-6736(15)00067-7
Cahill TH, Baddour LM, Habib G, MD,Hoen B,Salaun E, Pettersson GB, Schäfers HJ, Prendergast BD. Challenges in infective endocarditis. J Am Coll Cardiol 2017;69:325–44. doi: https://doi.org/10.1016/j.jacc.2016.10.066
Wang A, Gaca JG,Chu VH. Management Considerations in Infective Endocarditis. A Review. JAMA 2018;320(1):72-83. doi: https://doi.org/10.1001/jama.2018.7596
Shmueli H, Thomas F, Flint N, Setia G, Janjic A, Siegel RJ. Right-Sided Infective Endocarditis 2020: Challenges and Updates in Diagnosis and Treatment. J Am Heart Assoc. 2020;9: e017293. doi: https://doi.org/10.1161/JAHA.120.01729
Evin Y, Bearnot B, Paras ML, Zern EK, Dudzinsky DM, Soon CP, Jassar AS, Rosenfield K, Lira J, Lamber E, Wakeman SE, Sundt T. Diagnosis and management of infective endocarditis in people who inject drugs. JACC State of the Art Review. J Am Coll Cardiol 2022; 79:2037-2057. doi: https://doi.org/10.1016/j.jacc.2022.03.349
Philip J, Bond MC. Emergency considerations of infective endocarditis. Emerg Med Clin N Am 2022; 40:793-808. doi: https://doi.org/10.1016/j.emc.2022.07.001
Rajani R, Klein JL. Infective endocarditis: A contemporary update. Clinical Medicine 2020,20(1):31-35. doi: https://doi.org/10.7861/clinmed.cme.20.1.1
Benvenga, RM, Tribouilloy C, Michelena, HI,Silverio A, Arregle F, Martel H, Denev S, Bohbot Y, Hubert S, Renard S, Camoin L, Casalta AC, Casalta JP, Gouriet F, Riberi A, Lepidi H, Collart F, Raoult D, Drancourt M, Galasso G, DeSimone DC, Citro R, and Habib G. Clinical and Echocardiographic Features of Patients With Infective Endocarditis and Bicuspid Aortic Valve According to Echocardiographic Definition of Valve Morphology. J Am Soc Echocardiogr 2023; 36:760-8. doi: https://doi.org/10.1016/j.echo.2023.01.010
Sengupta S, Prendergast B, Jamiel A, Vieira MLC, Lancellotti P,Habib G et al. Socioeconomic variations determine the clinical presentation, aetiology, and outcome of infective endocarditis: a prospective cohort study from the ESC-EORP EURO-ENDO (European Infective Endocarditis) registry. European Heart Journal - Quality of Care and Clinical Outcomes, 9 (1), 2023, Pages 85–96Mocumbi AO, Ferreira MB, Sidi D, Yacoub MH.N Engl J Med. 2008 Jul 3;359(1):43-9. doi: https://doi.org/10.1056/NEJMoa0708629
Lancellotti P, Pibarot P, Chambers J. et al. Recommendations for the imaging assessment of prosthetic heart valves: a report from the European Association of Cardiovascular imaging endorsed by the Chinese Society of Echocardiography, the Inter-American Society of Echocardiography and the Brazilian Department of Cardiovascular Imaging. European Heart J Cardiovasc Imaging 2016; 17:589-90. doi: https://doi.org/10.1093/ehjci/jew025
Mgbojikwe N., Jones SR, Leucker TM., Brotman DJ. Infective endocarditis: Beyond the usual tests. Cleveland Clinic Journal of Medicine 2019;86(8):559-567. doi: https://doi.org/10.3949/ccjm.86a.18120
Suchá D, Symersky P, Tanis W. et al. Multimodality imaging assessment of prosthetic heart valves. Circ Cardiovasc Imaging.2015;8:e003703. doi: https://doi.org/10.1161/CIRCIMAGING.115.003703
Diaz S, Refoyo E, Valbuena-López S. et al. Utilidad de la tomografía computarizada con multidetectores en la endocarditis infecciosa. Revista Española de Cardiología 2016;69:442-454. doi: https://doi.org/10.1016/j.recesp.2015.12.007
Sabi L, Laas O, Habib G. et al. Positron Emission tomography/computed tomography for diagnosis of prosthetic valve endocarditis. J Am Coll Cardiol 2013;2374-2382. doi: https://doi.org/10.1016/j.jacc.2013.01.092
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Gustavo Restepo Molina
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
RETIC is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license https://creativecommons.org/licenses/by-nc-nd/4.0 which allows sharing, copying and redistribution of the material in any medium or format, under the following terms:
- Attribution: you must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests that the licensor endorses you or your use.
- Non-commercial: you may not use the material for commercial purposes.
- No Derivatives: if you remix, transform or build upon the material, you may not distribute the modified material.
- No Additional Restrictions: you may not apply legal terms or technological measures that legally restrict others from doing anything permitted by the license.
